Also trades as: NBRV (NASDAQ) · $vol 0M
NBRVF OTC
Nabriva Therapeutics plc
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -0.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$32M
-60.7% ▼
5Y CAGR: -19.8%
Total Liabilities
$28M
+3.3% ▲
5Y CAGR: +15.8%
Shareholders Equity
$3M
-93.8% ▼
5Y CAGR: -47.4%
Cash & Investments
$12M
-74.0% ▼
5Y CAGR: -32.2%
Total Debt
$5M
-35.0% ▼
5Y CAGR: +86.4%
Net Debt
-$7M
+81.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $102M | $86M | $41M | $48M | $12M |
| Short-Term Investments | $225K | $175K | $16K | $16K | $0 |
| Cash & ST Investments | $102M | $86M | $41M | $48M | $12M |
| Net Receivables | $5M | $3M | $4M | $13M | $7M |
| Inventory | $0 | $682K | $6M | $15M | $10M |
| Other Current Assets | $0 | $392K | $231K | $175K | $123K |
| Total Current Assets | $109M | $91M | $57M | $80M | $31M |
| Property, Plant & Equip. | $1M | $2M | $768K | $233K | $280K |
| Goodwill & Intangibles | $98K | $91K | $80K | $31K | $3K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $428K | $378K | $370K | $380K | $378K |
| Total Non-Current Assets | $2M | $3M | $1M | $644K | $661K |
| Total Assets | $110M | $94M | $58M | $81M | $32M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $5M | $3M | $4M | $5M |
| Short-Term Debt | $0 | $0 | $2M | $4M | $5M |
| Deferred Revenue | $0 | $0 | $750K | $374K | $0 |
| Other Current Liabilities | $2M | $3M | $2M | $2M | $1M |
| Total Current Liabilities | $18M | $17M | $19M | $22M | $28M |
| Long-Term Debt | $24M | $35M | $6M | $4M | $388K |
| Other Non-Current Liab. | $264K | $2M | $1M | $954K | $479K |
| Total Non-Current Liabilities | $24M | $36M | $7M | $5M | $867K |
| Total Liabilities | $42M | $53M | $25M | $28M | $28M |
| — Equity — | |||||
| Common Stock | $670K | $95K | $211K | $23K | $32K |
| Retained Earnings | -$394M | -$477M | -$546M | -$596M | -$653M |
| Accumulated OCI | $27K | $27K | $27K | $27K | $27K |
| Total Stockholders Equity | $69M | $41M | $33M | $53M | $3M |
| Total Liabilities & Equity | $110M | $94M | $58M | $81M | $32M |
| — Key Metrics — | |||||
| Total Debt | $24M | $35M | $8M | $8M | $5M |
| Net Debt | -$78M | -$52M | -$34M | -$40M | -$7M |
| Total Investments | $225K | $175K | $16K | $16K | $0 |